tiprankstipranks
Smith & Nephew Snats (SNN)
NYSE:SNN
US Market
Want to see SNN full AI Analyst Report?

Smith & Nephew Snats (SNN) Blogger Opinions & Sentiment

203 Followers

Blogger Sentiment

Neutral 50.00%
Sector Average
Neutral
SNN Blogger sentiment is based on 4 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
50% SeekingAlpha
25% Zacks
25% Motley Fool UK
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

SNN advances surgical robotics through Imperial College partnership
Zacks
Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release
SeekingAlpha
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

3 UK stocks to consider buying for reliable dividend income in 2026
Motley Fool UK
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of SNN?
Seeking Alpha’s Retirement Pot has a Bullish Sentiment.
    What do Motley Fool contributors think of SNN?
    Currently there's no blogger sentiment for SNN.
    What Is SNN’s Blogger Sentiment?
    SNN’s Blogger Sentiment is Neutral.
      What was the most recent blogger prediction for SNN?
      The most recent blogger prediction for SNN was made by Zacks Equity Research, who was Bearish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          SMMTSummit Therapeutics
          TGTXTG Therapeutics
          PGENPrecigen